[
  {
    "ts": null,
    "headline": "Should You Invest in Medtronic (MDT)?",
    "summary": "Matrix Asset Advisors, an asset management company, released its third-quarter 2023 investor letter. A copy of the same can be downloaded here. In 2025, the firm anticipates further economic growth with a slight slowdown from the 3% GDP in the previous quarter. Through September 30, Matrix’s Large Cap Value portfolio (LCV) was up in the high […]",
    "url": "https://finnhub.io/api/news?id=a3d66371559d0fe88b46a58f867dab522cafe4dca7fb5b549a17be57db1f2f74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734354190,
      "headline": "Should You Invest in Medtronic (MDT)?",
      "id": 132014238,
      "image": "https://media.zenfs.com/en/insidermonkey.com/2fe58d3328d7e96d080894bad3b9fe48",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Matrix Asset Advisors, an asset management company, released its third-quarter 2023 investor letter. A copy of the same can be downloaded here. In 2025, the firm anticipates further economic growth with a slight slowdown from the 3% GDP in the previous quarter. Through September 30, Matrix’s Large Cap Value portfolio (LCV) was up in the high […]",
      "url": "https://finnhub.io/api/news?id=a3d66371559d0fe88b46a58f867dab522cafe4dca7fb5b549a17be57db1f2f74"
    }
  },
  {
    "ts": null,
    "headline": "PFA to surpass radiofrequency ablation in 2025: Citi survey",
    "summary": "Pulsed field ablation could soon be used in the majority of electrophysiology procedures to treat atrial fibrillation as Medtronic, Boston Scientific and Johnson & Johnson battle for market share.",
    "url": "https://finnhub.io/api/news?id=a52cacf004c35f4b122a6b453ab24524042d7b25cdbb2daddd11f4458e05ca4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734351171,
      "headline": "PFA to surpass radiofrequency ablation in 2025: Citi survey",
      "id": 132015319,
      "image": "https://imgproxy.divecdn.com/q3o076EExkKsEqYqme3_fAelP6tkkQT0AR0DEtz8ThI/g:nowe:501:123/c:1773:1002/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9NZWR0cm9uaWNfQWxsX2luX09uZV9NZWR0cm9uaWNfU3BoZXJlXzlfQ2F0aGV0ZXItX0FmZmVyYS5qcGc=.webp",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Pulsed field ablation could soon be used in the majority of electrophysiology procedures to treat atrial fibrillation as Medtronic, Boston Scientific and Johnson & Johnson battle for market share.",
      "url": "https://finnhub.io/api/news?id=a52cacf004c35f4b122a6b453ab24524042d7b25cdbb2daddd11f4458e05ca4c"
    }
  }
]